Low Expression of KAT6B May Affect Prognosis in Hepatocellular Carcinoma

Low Expression of KAT6B May Affect Prognosis in Hepatocellular Carcinoma

Aims: Lysine acetyltransferase 6B (KAT6B), is a histone acetyltransferase implicated to have a role in tumor suppression. However, the relationship between KAT6B and hepatocellular carcinoma (HCC) is unclear. The purpose of this study was to detect the expression of KAT6B in HCC tissues and analyze...

Full description

Bibliographic Details
Main Authors:	Junjie Jiang, Hui-Ju Wang, Xiao-Zhou Mou, Huanqing Zhang, YiZhen Chen, Zhi-Ming Hu
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-08-01
Series:	Technology in Cancer Research & Treatment
Online Access:	https://doi.org/10.1177/15330338211033063

Similar Items

KAT7-acetylated YBX1 promotes hepatocellular carcinoma proliferation by reprogramming nucleotide metabolism
by: He Huang, et al.
Published: (2025-02-01)

ERα status of invasive ductal breast carcinoma as a result of regulatory interactions between lysine deacetylases KAT6A and KAT6B
by: Mateusz Olbromski, et al.
Published: (2024-11-01)

LbKAT3 may assist in mycorrhizal potassium uptake, and overexpression of LbKAT3 may promote potassium, phosphorus, and water transport from arbuscular mycorrhizal fungi to the host plant
by: Xia Han, et al.
Published: (2023-06-01)

Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions
by: Qiuxian Zheng, et al.
Published: (2021-06-01)

KAT 341 - POLLUTION AND ENVIRONMENTAL CHEMISTRY APR-MAY 09.
by: PPSK, Pusat Pengajian Sains Kimia
Published: (2009)

Implications of pseudogenes for the prognosis of hepatocellular carcinoma
by: Zaoqu Liu, et al.
Published: (2023-02-01)

Intratumoral perfusion may affect microwave ablation area of hepatocellular carcinoma
by: Fubo Zhou, et al.
Published: (2023-12-01)

Coilin Affects the Prognosis of Hepatocellular Carcinoma Through Cell Cycle and Apoptosis
by: Lu L, et al.
Published: (2025-02-01)

P300: Expanding the neuropsychological phenotype of KAT6B disorders: Overlapping features with KAT6A syndrome
by: Rowena Ng, et al.
Published: (2024-01-01)

Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation
by: Xia-Hui Lin, et al.
Published: (2023-03-01)

Glycogen synthase kinase-3β is associated with the prognosis of hepatocellular carcinoma and may mediate the influence of type 2 diabetes mellitus on hepatocellular carcinoma.
by: Guoliang Qiao, et al.
Published: (2014-01-01)

DUSP12 regulates the tumorigenesis and prognosis of hepatocellular carcinoma
by: Gaoda Ju, et al.
Published: (2021-08-01)

KAT6B overexpression rescues embryonic lethality in homozygous null KAT6A mice restoring vitality and normal lifespan
by: Maria. I. Bergamasco, et al.
Published: (2025-02-01)

Tumor size may influence the prognosis of solitary hepatocellular carcinoma patients with cirrhosis and without macrovascular invasion after hepatectomy
by: Bin-yong Liang, et al.
Published: (2021-08-01)

Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis: Editorial on “Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging”
by: Abdelrahman M Attia, et al.
Published: (2024-10-01)

Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?
by: Ming-Wei Lai, et al.
Published: (2019-03-01)

Cuproptosis- and m6A-Related lncRNAs for Prognosis of Hepatocellular Carcinoma
by: Yuezhi Zhu, et al.
Published: (2023-08-01)

ASPM May be Related to the Malignant Progression of Hepatitis B and is Associated With a Poor Prognosis of Hepatocellular Carcinoma
by: Siyou Tan, et al.
Published: (2022-03-01)

Primary Hepatocellular carcinoma: management and prognosis
by: Murtaza Mustafa, et al.
Published: (2016)

Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma
by: Zhigang Ren, et al.
Published: (2020-01-01)

Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
by: Ting Liu, et al.
Published: (2023-10-01)

The Kat in the HAT: The Histone Acetyl Transferase Kat6b (MYST4) Is Downregulated in Murine Macrophages in Response to LPS
by: Smita Shukla, et al.
Published: (2018-01-01)

The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma
by: Atsushi Kawamura, et al.
Published: (2022-08-01)

Multiple m6A RNA methylation modulators promote the malignant progression of hepatocellular carcinoma and affect its clinical prognosis
by: Nanfang Qu, et al.
Published: (2020-02-01)

KAT 244 & KAT 344 - KAEDAH PEMISAHAN FEB. 98.
by: PPSK, Pusat Pengajian Sains Kimia
Published: (1998)

Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma
by: Bing-Bing Shang, et al.
Published: (2021-10-01)

Astragaloside IV inhibits cell viability and glycolysis of hepatocellular carcinoma by regulating KAT2A-mediated succinylation of PGAM1
by: Yuanzhang Zhu, et al.
Published: (2024-06-01)

Clinical features and the genetic analysis of KAT6B-related diseases caused by a de novo mutation of the KAT6B gene c.621+1G>A
by: Yu Yang, et al.
Published: (2022-02-01)

Factors Affecting the Prognosis of Small Hepatocellular Carcinoma in Taiwanese Patients Following Hepatic Resection
by: Chih-Jan Ko, et al.
Published: (2011-01-01)

Genomic aberrations in the HTPAP promoter affect tumor metastasis and clinical prognosis of hepatocellular carcinoma.
by: Jin-Cai Wu, et al.
Published: (2014-01-01)

Canopy Homolog 2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma with Tumor Hemorrhage
by: Dong Wang, et al.
Published: (2018-11-01)

Quantitative acetylome analysis reveals histone modifications that may predict prognosis in hepatitis B‐related hepatocellular carcinoma
by: Xiaoqiang Chai, et al.
Published: (2021-03-01)

Effect of Serum Interleukin-6 Concentration on the Prognosis After Radiotherapy for Patients With Hepatocellular Carcinoma
by: Yong Hu, et al.
Published: (2024-01-01)

Analysis of the role of m6A and lncRNAs in prognosis and immunotherapy of hepatocellular carcinoma
by: Yan Xu, et al.
Published: (2022-09-01)

An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
by: Zhenyu Zhang, et al.
Published: (2022-03-01)

NLRP6-Dependent Pyroptosis-Related lncRNAs Predict the Prognosis of Hepatocellular Carcinoma
by: La Zhang, et al.
Published: (2022-03-01)

Kat Mülkiyetinde Kat Malikinin Mimari Projeye Aykırı Yapı Yapması
by: Süheyla Zorlu
Published: (2023-12-01)

CTNNB1 Alternation Is a Potential Biomarker for Immunotherapy Prognosis in Patients With Hepatocellular Carcinoma
by: Lin Chen, et al.
Published: (2021-10-01)

Expression of IER3 in hepatocellular carcinoma: clinicopathology, prognosis, and potential regulatory pathways
by: Fei-Yan He, et al.
Published: (2022-03-01)

Sleep, Behavior, and Adaptive Function in KAT6A Syndrome
by: Clay Smith, et al.
Published: (2021-07-01)